Why Syapse?

Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models.

With Syapse, healthcare systems can implement an enterprise-wide precision medicine program that spans multiple clinical service lines and bridges geographically distributed sites. Syapse Precision Medicine Platform integrates clinical data from siloed data sources, captures structured genomic and other molecular data, enables institutional experts to systematize best-practice guidelines through clinical decision support tools, and tracks outcomes for quality improvement.

Additionally, with Syapse, oncologists can access patient clinical, pathology, radiology, treatment, and molecular data in a unified, longitudinal view, eliminating the need to search across siloed systems. Clinicians can easily access the full scope of patient data to answer key clinical questions. It enables better coordination for care teams managing large volumes of complex cancer cases, and enables decision support by surfacing relevant data and guidance for making the right treatment decisions.

Market Opportunity

Syapse’s technology provides integral software infrastructure for any healthcare provider utilizing genomics, molecular and high-complexity clinical data in the care of their patients. While Syapse’s platform can be applied to any disease area, early customers have focused on oncology. In October 2015, Oliver Wyman estimated that the market opportunity for Precision Medicine hubs is $200 billion annually.

Company Milestones

  • Syapse’s platform is selected by the American Society of Clinical Oncology (ASCO) for its Targeted Agent and Profiling Utilization Registry (TAPUR) Study
  • Syapse partners with PierianDX to accelerate precision medicine programs for health systems
  • Syapse announces collaboration with Caris Life Sciences for oncology data aggregation
  • Syapse raises $25 million in Series C funding with participation from Safeguard Scientifics
  • Syapse launches Global Partner Program to enhance and accelerate the implementation of the Syapse Precision Medicine Platform at healthcare organizations globally
  • Syapse partners with Henry Ford Health System to launch oncology precision medicine program
  • Syapse partners with Catholic Health Initiatives to launch a national oncology precision medicine program
  • Syapse Announces Ken Tarkoff as New CEO

The cornerstone of successful precision medicine programs.